Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ImmunoGen Inc.

    NASDAQ: IMGN · Real-Time Price · USD
    31.23
    0.00 (0.00%)
    At close: Feb 09, 2024, 9:58 PM

    ImmunoGen Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 108.78M 69.86M
    Cost of Revenue
    		 176K n/a
    Gross Profit
    		 108.61M 69.86M
    Operating Income
    		 -220.89M -125.07M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -221.71M -139.3M
    Net Income
    		 -222.93M -139.3M
    Selling & General & Admin
    		 116.13M 43.81M
    Research & Development
    		 213.37M 151.12M
    Other Expenses
    		 -994K -1.13M
    Operating Expenses
    		 329.5M 194.93M
    Interest Expense
    		 4.17M 13.15M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 329.68M 194.93M
    Income Tax Expense
    		 1.22M n/a
    Shares Outstanding (Basic)
    		 253.63M 206.15M
    Shares Outstanding (Diluted)
    		 253.63M 206.15M
    EPS (Basic)
    		 -0.88 -1.08
    EPS (Diluted)
    		 -0.88 -1.08
    EBITDA
    		 -220.1M -124.19M
    EBIT
    		 -217.55M -135.14M
    Depreciation & Amortization
    		 1.78M 2.02M

    Add to Watchlist